Relief Therapeutics Holding AG (RLFTF)

[mc67]

In 60 min. In this video we will revisit Aviptadil, also known as RLF-100, a synthetic Vasoactive Intestinal Peptide that is current undergoing clinical trials to treat COVID-19.

New data came out on Trial Site on 21 patients who received this therapy under the Emergency Use Authorization because they were so critically ill.

Interestingly, they had a 9x lower mortality than their control group. We do not have all the data published to compare these two groups, but nonetheless a very interesting finding!

We will discuss how this therapy works, the published data, and the ongoing clinical trials. Check out the video for all the details!